XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Other Comprehensive Loss [Member]
Total
Balance at Jun. 30, 2020 $ 26,032 $ 26,134,819 $ (21,176,799) $ (125,038) $ 4,859,014
Balance (in shares) at Jun. 30, 2020 26,032,263        
Fair value of vested stock options $ 0 419,785 0 0 419,785
Fair value of vested restricted common stock $ 143 186,811 0 0 186,954
Fair value of vested restricted common stock (in shares) 143,474        
Repurchase of common stock $ (56) (127,218) 0 0 (127,274)
Repurchase of common stock (in shares) (56,667)        
Common stock issued upon exercise of stock options $ 82 14,018 0 0 14,100
Common stock issued upon exercise of stock options (in shares) 81,938        
Common stock issued upon exercise of warrants $ 65 81,186     81,251
Common stock issued upon exercise of warrants (in shares) 65,000        
Net income (loss) for the period $ 0 0 (245,961) 0 (245,961)
Foreign currency translation 0 0 0 6,681 6,681
Balance at Dec. 31, 2020 $ 26,266 26,709,401 (21,422,760) (118,357) 5,194,550
Balance (in shares) at Dec. 31, 2020 26,266,008        
Balance at Jun. 30, 2020 $ 26,032 26,134,819 (21,176,799) (125,038) 4,859,014
Balance (in shares) at Jun. 30, 2020 26,032,263        
Balance at Jun. 30, 2021 $ 26,498 26,982,052 (21,461,888) (119,577) 5,427,085
Balance (in shares) at Jun. 30, 2021 26,498,215        
Balance at Sep. 30, 2020 $ 26,191 26,261,156 (21,162,154) (123,873) 5,001,320
Balance (in shares) at Sep. 30, 2020 26,190,713        
Fair value of vested stock options $ 0 342,158 0 0 342,158
Fair value of vested restricted common stock $ 23 93,767 0 0 93,790
Fair value of vested restricted common stock (in shares) 23,474        
Repurchase of common stock $ (31) (68,848) 0 0 (68,879)
Repurchase of common stock (in shares) (31,167)        
Common stock issued upon exercise of stock options $ 18 (18) 0 0 0
Common stock issued upon exercise of stock options (in shares) 17,988        
Common stock issued upon exercise of warrants $ 65 81,186 0 0 81,251
Common stock issued upon exercise of warrants (in shares) 65,000        
Net income (loss) for the period $ 0 0 (260,606) 0 (260,606)
Foreign currency translation 0 0 0 5,516 5,516
Balance at Dec. 31, 2020 $ 26,266 26,709,401 (21,422,760) (118,357) 5,194,550
Balance (in shares) at Dec. 31, 2020 26,266,008        
Balance at Jun. 30, 2021 $ 26,498 26,982,052 (21,461,888) (119,577) 5,427,085
Balance (in shares) at Jun. 30, 2021 26,498,215        
Fair value of vested stock options $ 0 127,668 0 0 127,668
Fair value of vested restricted common stock $ 251 343,730 0 0 343,981
Fair value of vested restricted common stock (in shares) 250,997        
Repurchase of common stock $ (28) (67,784) 0 0 (67,812)
Repurchase of common stock (in shares) (27,316)        
Common stock issued upon exercise of stock options $ 46 30,625 0 0 $ 30,671
Common stock issued upon exercise of stock options (in shares) 45,160       49,634
Common stock issued upon exercise of warrants $ 50 59,450 0 0 $ 59,500
Common stock issued upon exercise of warrants (in shares) 50,000        
Net income (loss) for the period $ 0 0 (853,587) 0 (853,587)
Foreign currency translation 0 0 0 (2,790) (2,790)
Balance at Dec. 31, 2021 $ 26,817 27,475,741 (22,315,475) (122,367) 5,064,716
Balance (in shares) at Dec. 31, 2021 26,817,056        
Balance at Sep. 30, 2021 $ 26,594 27,098,585 (21,833,890) (122,552) 5,168,737
Balance (in shares) at Sep. 30, 2021 26,594,119        
Fair value of vested stock options $ 0 55,669 0 0 55,669
Fair value of vested restricted common stock $ 135 244,735 0 0 244,870
Fair value of vested restricted common stock (in shares) 135,088        
Repurchase of common stock $ (6) (13,325) 0 0 (13,331)
Repurchase of common stock (in shares) (5,951)        
Common stock issued upon exercise of stock options $ 44 30,627 0 0 30,671
Common stock issued upon exercise of stock options (in shares) 43,800        
Common stock issued upon exercise of warrants $ 50 59,450 0 0 59,500
Common stock issued upon exercise of warrants (in shares) 50,000        
Net income (loss) for the period $ 0 0 (481,585) 0 (481,585)
Foreign currency translation 0 0 0 185 185
Balance at Dec. 31, 2021 $ 26,817 $ 27,475,741 $ (22,315,475) $ (122,367) $ 5,064,716
Balance (in shares) at Dec. 31, 2021 26,817,056